Full name
LUBELSKIE ZAKŁADY FARMACEUTYCZNE "POLFA" SPÓŁKA AKCYJNA
uses securityreCAPTCHA
32.50.Z - Production of medical devices, instruments, and products, including dental products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
22.22.Z - Manufacture of plastic packaging
22.29.Z - Manufacture of rubber and plastic products
25.62.Z - Production of locks and hinges
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.46.Z - Wholesale trade of pharmaceutical and medical products
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
82.92.Z - Packaging activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,5 | 0,1 | 0,1 | -59,3 |
EBITDA | 3,3 | 3,4 | 3,8 | 11,5 |
Short time liabilities | 8,9 | 5,6 | 5,2 | -7 |
Equity capital | 20,8 | 20,8 | 20,8 | 0,2 |
Operating profit (EBIT) | 0,8 | 0,8 | 0,7 | -11,6 |
Assets | 34,6 | 35,1 | 32,8 | -6,5 |
Net profit (loss) | 0,2 | 0 | 0 | 951 |
Cash | 1,3 | 1,7 | 3,2 | 82,3 |
Liabilities and provisions for liabilities | 13,8 | 14,3 | 12 | -16,1 |
Net income from sale | 22,2 | 30,4 | 31,5 | 3,6 |
Working assets | 9,9 | 10,5 | 9,8 | -6,9 |
Depreciation | 2,6 | 2,6 | 3,1 | 18 |
% | % | % | p.p. | |
Profitability of capital | 0,7 | 0 | 0,2 | 0,2 |
Equity capital to total assets | 60,1 | 59,2 | 63,4 | 4,2 |
Gross profit margin | 2,1 | 0,4 | 0,2 | -0,2 |
EBITDA Margin | 15 | 11,1 | 12 | 0,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 146 | 67 | 60 | -7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane